ABSTRACT
Introducción:El dolor neuropático es, en numerosas ocasiones, un dolor de difícil manejo que precisa la combinación de diferentes grupos terapéuticos para su control óptimo.Método:La lidocaína es un anestésico local y su uso endovenoso es necesario ocasionalmente para el tratamiento del dolor neuropático; no hay experiencia en su uso domiciliario.Resultados:Realizamos la infusión endovenosa domiciliaria con lidocaína en 2 pacientes con dolor neuropático refractario con mejoría clínica.Conclusiones:La infusión de lidocaína endovenosa en domicilio es una técnica segura y eficaz en pacientes con dolor neuropático. (AU)
Introduction:Neuropathic pain is a often difficult to control pain and is suitable of different therapeutic approaches.Method:Lidocaine is a local anesthesic and its endovenous use is sometimes necessary to control neuropathic pain. There is no reported use of this drug at home.Results:We performed the lidocaine endovenous infusion in two patients with neuropathic pain achieving significant clinical improvement.Conclusions:Endovenous lidocaine infusion at home, is a safe and effective proceeding for patients with neuropathic pain. (AU)
Subject(s)
Humans , Male , Female , Middle Aged , Palliative Care/methods , Home Care Services , Lidocaine/therapeutic use , Pain Measurement/methodsABSTRACT
La infección por SARS-CoV-2 es una realidad emergente y urgente. No hay apenas datos sobre la afección en los pacientes en cuidados paliativos por esta infección
SARS-CoV-2 infection is an emergent and urgent reality. Hardly any data are available regarding the condition of patients on palliative care because of this infection
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Coronavirus Infections/transmission , Palliative Care/statistics & numerical data , Cross Infection/epidemiology , Severe acute respiratory syndrome-related coronavirus/pathogenicity , Terminally Ill/statistics & numerical data , Epidemiologic StudiesABSTRACT
No disponible
Subject(s)
Humans , Adult , Middle Aged , Aged , Aged, 80 and over , Health Communication/ethics , Palliative Care/psychology , Patient Satisfaction , Truth Disclosure , Professional-Patient Relations , Terminal Care/psychologyABSTRACT
El término neoplasia primaria múltiple define a la presencia de dos o más procesos neoplásicos de distinto origen simultáneamente. Existe poca información de los pacientes en cuidados paliativos con esta patología. Presentamos una serie de 10 casos seguidos en nuestra unidad
The term multiple primary neoplasm is defined as the occurrence of two or more neoplastic processes of different origin that develop simultaneously. Information is sparse regarding patients with this condition in the palliative care setting. We report herein a series of 10 consecutive cases seen in our unit
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Neoplasms, Multiple Primary , Palliative Care/methods , Survivorship , Risk Factors , Time FactorsSubject(s)
BCG Vaccine/adverse effects , Chemical and Drug Induced Liver Injury/etiology , Granuloma/etiology , Hypersensitivity, Delayed/etiology , Tuberculosis, Hepatic/etiology , Administration, Intravesical , Aged , Antitubercular Agents/adverse effects , Antitubercular Agents/therapeutic use , BCG Vaccine/immunology , BCG Vaccine/therapeutic use , Carcinoma, Transitional Cell/surgery , Carcinoma, Transitional Cell/therapy , Chemical and Drug Induced Liver Injury/diagnosis , Cholangitis/etiology , Cholecystectomy , Cholecystitis/etiology , Cholecystitis/surgery , Combined Modality Therapy , Cystectomy/methods , Diagnosis, Differential , Granuloma/microbiology , Humans , Hypersensitivity, Delayed/diagnosis , Male , Models, Biological , Mycobacterium bovis/immunology , Mycobacterium bovis/isolation & purification , Postoperative Complications/etiology , Postoperative Complications/microbiology , Tuberculosis, Hepatic/diagnosis , Tuberculosis, Hepatic/microbiology , Urinary Bladder Neoplasms/surgery , Urinary Bladder Neoplasms/therapySubject(s)
Humans , Male , Young Adult , Candida/classification , Candidiasis/microbiology , Cross Infection/microbiology , Fungemia/microbiology , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Cross Infection/drug therapy , Fungemia/drug therapy , Young AdultSubject(s)
Eosinophilia/etiology , Intestinal Diseases, Parasitic/diagnosis , Trichuriasis/diagnosis , Adoption , Amebiasis/blood , Amebiasis/complications , Amebiasis/drug therapy , Animals , Anthelmintics/therapeutic use , Antiprotozoal Agents/therapeutic use , Blastocystis Infections/blood , Blastocystis Infections/complications , Blastocystis Infections/drug therapy , Blastocystis hominis , Child , Drug Therapy, Combination , Dysentery, Amebic/blood , Dysentery, Amebic/complications , Dysentery, Amebic/drug therapy , Ethiopia/ethnology , Feces/parasitology , Female , Giardia lamblia , Giardiasis/blood , Giardiasis/complications , Giardiasis/drug therapy , Humans , Intestinal Diseases, Parasitic/blood , Intestinal Diseases, Parasitic/complications , Intestinal Diseases, Parasitic/drug therapy , Mebendazole/therapeutic use , Metronidazole/therapeutic use , Spain , Trichuriasis/blood , Trichuriasis/complications , Trichuriasis/drug therapy , Trichuriasis/parasitology , Trichuris/classification , Trichuris/isolation & purificationABSTRACT
El género salmonella incluye enterobacterias responsables de numerosos casos de patología infecciosa. Las complicaciones focales son poco frecuentes. Se realizó el estudio retrospectivo entre los años 1996 y 2002 de los casos diagnosticados en el Hospital Clínico de Santiago de Compostela, España. Se diagnosticaron 153 casos como infección por salmonella, de los que 13 (8,5%) presentaron complicaciones. Las edades incluidas fueron entre 17 y 80 años, con una mediana de 37 años, de los que nueve casos (69%) eran hombres y en 7 (54%) no existían factores de riesgo asociados. En 12 pacientes (93%) existía antecedente de gastroenteritis. Los diagnósticos se realizaron por coprocultivo (5 casos), en 6 pacientes (46%) por hemocultivo, en otros 3 casos ambos fueron positivos. Las complicaciones incluyeron absceso esplénico, neumonía, endocarditis, endarteritis, sepsis, hepatitis y artritis reactiva. No existió un claro predominio estacional. El antibiótico pautado fue en 8 pacientes (64%) ciprofloxacino; tres pacientes fueron intervenidos. Dos pacientes fallecieron. En esta serie de casos se concluyó que la prevalencia y morbimortalidad de complicaciones, es elevada. La presentación más habitual es sepsis (4 casos), neumonía (3 casos) y absceso esplénico (2 casos), frente a la osteomuscular o partes blandas (1 caso). Se detectó bacteriemia en un porcentaje elevado de los casos...
Genus salmonella includes enterobacteriaes responsible of a great amount of infectious diseases. Focal complications are not frecuent. We conducted a 5 retrospective study between 1996 and 2002. We included 153 cases with salmonella infection, 13 of which (8, 5%) with ages between 17 and 80 years (median 37) presented focal complications. Nine of the patients were male (69%) and in 7 cases (54%) risk factors were present, 12 (93%) presented previously gastroenteric signs. Microbiological diagnosis established through stool examination (5 cases), in 6 (46%) with blood culture, in other 3 cases, both were positive. Complications included splenic abscess, pneumonia,endocarditis, endarteritis, sepsis, hepatitis and reactive arthritis. No clear seasonal pattern was established. Eight patients (64%) received ciprofloxacin. Three patients were surgically treated. Two patients died. Conclusion: In our series prevalence and morbimortality in focal complications is high. The most common presentation was sepsis (4 cases), pneumonia (3) and splenic abscess (2). Bacteraemia was documented in a high percentage of cases. No seasonal pattern was established...
Subject(s)
Salmonella , Salmonella Infections , Salmonella typhi , Gastroenteritis , Pneumonia , SepsisABSTRACT
BACKGROUND: Although common and usually benign, hiccups can be an extremely uncomfortable disease. There is not much information about persistent and refractory hiccups. AIM: To report clinical features of patients admitted in a hospital due to hiccup. PATIENTS AND METHODS: A retrospective study and prospective follow up of patients admitted for hiccup in Hospital Clínico de Santiago de Compostela between January 1998 and May 2005. RESULTS: Twenty four patients (age 47 to 91 years, 23 males) were studied. Nineteen (79%) were admitted because of persistent hiccups. In twenty one patients, at inverted exclamation markeast one organic etiology was identified, and thirteen patients presented two or more possible associated conditions. The most common possible causes were digestive tract disorders, followed by central nervous system diseases. Twelve patients had a history of exposure to drugs that potentially could cause hiccups, mainly corticosteroids and benzodiazepines. Chlorpromazine was the first choice treatment in 23 patients, but seven required a second line drug. Average hospital stay was 13 days (range 3-90 days). Twelve patients died during follow up. Death occurred during the first three months of follow up in 61%. CONCLUSIONS: Persistent hiccup is often associated with organic conditions, specially advanced tumors of the digestive tract. It is usually associated with a bad prognosis.
Subject(s)
Hiccup/etiology , Adrenal Cortex Hormones/adverse effects , Aged , Aged, 80 and over , Benzodiazepines/adverse effects , Chlorpromazine/therapeutic use , Digestive System Neoplasms/complications , Female , Follow-Up Studies , Hiccup/drug therapy , Humans , Length of Stay , Male , Middle Aged , Retrospective Studies , Spain , Time FactorsABSTRACT
BACKGROUND: Pacemaker infection is a severe process affecting 1-7% of implants. Pulse generator pocket infection is most common. Endocarditis in patients with pacemakers is quite rare. Clinical signs include systemic-related symptoms and severe complications in as many as 40% of cases. The aim of our study was to review our experience and to analyze the epidemiology and treatment of those patients diagnosed as having pacemaker lead endocarditis. METHODS: A retrospective study included all patients diagnosed as having pacemaker endocarditis in our hospital from 1996 to 2002. RESULTS: Fifty-nine patients with pacemaker-related infection were identified, including 39 (66%) with pocket infection. Fever occurred in 25 patients (42%). In 39 patients, a germ was isolated, corresponding to Staphylococcus spp. in 22 (56%). Transthoracic echocardiography demonstrated vegetations in 7 patients (12%), whereas transesophageal echocardiography disclosed abnormal appearances on the pacemaker lead in 10 patients (17%). Ten patients were treated exclusively with antibiotics, while 38 patients required the removal of all infected material. Two patients died. CONCLUSIONS: The diagnosis of endocarditis related to pacemaker infection should be suspected in the presence of fever. High morbidity and mortality are associated with this disease. Prompt treatment, including in some cases removal of the device, is mandatory.
Subject(s)
Peer Review , Periodicals as Topic/standards , Bibliometrics , Chile , Editorial Policies , HumansSubject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Doxycycline/therapeutic use , Methicillin Resistance , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Adult , Aged , Aged, 80 and over , Arthritis, Infectious/drug therapy , Bacteremia/microbiology , Drug Therapy, Combination , Female , Humans , Immunocompromised Host , Male , Middle Aged , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Treatment OutcomeABSTRACT
No disponible
Subject(s)
Humans , Staphylococcus aureus/pathogenicity , Staphylococcal Infections/drug therapy , Anti-Bacterial Agents/therapeutic useSubject(s)
Humans , Peer Review , Periodicals as Topic/standards , Bibliometrics , Chile , Editorial PoliciesABSTRACT
There is little information on patients 50 years or older with HIV infection since the start of the HAART era. We performed a descriptive cross-sectional study during 2004 including 28 patients aged 52 to 87 years. Eighteen patients were men (64%) and sexual transmission was the risk factor in 23 (81%). Four patients (14%) fulfilled slow progression criteria and 13 (46%) belonged to the C3 category. Twenty-four patients were on HAART, with optimal adherence. All the patients were receiving HIV-unrelated medications to treat comorbid conditions. Hence, the profile of these patients is as follows: mainly male with sexually transmitted infection, severe immunodeficiency at the diagnosis, and frequent comorbid processes.
